Breast cancer incidence after the introduction of mammography screening: What should be expected?

Cancer

Volumn 106, Issue 9, 2006, Pages 1883-1890

  Svendsen, Anne Louise ^a   Olsen, Anne Helene ^a   Von Euler Chelpin, My ^a   Lynge, Elsebeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Breast; Malignant neoplasms; Mammography; Overdiagnosis; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER SCREENING; DENMARK; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL;

AGE FACTORS; AGED; BREAST NEOPLASMS; DENMARK; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; TIME FACTORS;

EID: 33646366677     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21823     Document Type: Article

References (15)

1. Rosenberg J, Chia YL, Plevritis S. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Breast Cancer Res Treat. 2005;89:47-54.
2. Lynge E. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. APMIS Suppl. 1998;83:1-44.
3. Njor SH, Olsen AH, Bellstrom T, et al. Mammography screening in the county of Fyn November 1993-December 1999. APMIS Suppl. 2003;110:1-33.
4. Jensen A, Olsen AH, von Euler-Chelpin M, Njor SH, Vejborg I, Lynge E. Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer. 2005;113:464-470.
5. Lagerlund M, Maxwell AE, Bastani R, Thurfjell E, Ekbom A, Lambe M. Sociodemographic predictors of non-attendance in invitational, mammography screening- a population-based register study (Sweden). Cancer Causes Control. 2002;13:73-82.
6. Zackrisson S, Andersson I, Manjer J, Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer. 2004;108:754-760.
7. Vejborg I, Olsen AH, Jensen M-B, Rank F, Tange UB, Lynge E. Early outcome of mammography screening in Copenhagen 1991-99. J Med Screen. 2002;9:115-119.
8. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AMF, Chen THH. The randomized trials of breast cancer screening: what have we learned [review]? Radiol Clin North Am. 2004;42:791-806.
9. Das B, Feuer EJ, Mariotto A. Geographic association between mammography use and mortality reduction in the US. Cancer Causes Control. 2005;16:691-699.
10. Boer R, Warmerdam P, de Koning H, van Oortmarssen G. Extra incidence caused by mammographic screening. Lancet. 1994;343:979.
11. Paci E, Warwick J, Falini P, Duffy SW. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen. 2004;11:23-27.
12. Anttila A, Koskela J, Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen. 2002;9:153-158.
13. Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ. 2004;328:921-924.
14. Response to: Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. Available at URL: http://bmj.bmjjournals.com/cgi/eletters/328/ 7445/921 [accessed July 19, 2005].
15. Moller B, Weedon-Fekjaer H, Hakulinen T, et al. The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev. 2005;14:117-128.